Skip to main content

Clinical Considerations of the Role of Palbociclib in the Management of Advanced Breast Cancer Patients With and Without Visceral Metastases.

Author
Abstract
:

This report assesses the efficacy and safety of palbociclib plus endocrine therapy (ET) in women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer (ABC) with or without visceral metastases.

Year of Publication
:
2018
Journal
:
Annals of oncology : official journal of the European Society for Medical Oncology
Date Published
:
2018
ISSN Number
:
0923-7534
URL
:
https://academic.oup.com/annonc/article-lookup/doi/10.1093/annonc/mdx797
DOI
:
10.1093/annonc/mdx797
Short Title
:
Ann Oncol
Download citation